Gene therapy may restore mobility after spinal cord injury, animal study finds
Gene therapy has restored mobility in mice with completely severed spinal cords, researchers report.
Stay updated with breaking news from Motor Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gene therapy has restored mobility in mice with completely severed spinal cords, researchers report.
Late edition of the television news program by the Fox News editorial staff.
Late edition of the television news program by the Fox News editorial staff.
20.03.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new long-term data for Evrysdi (risdiplam) in a broad range of people aged 2-25 years with spinal muscular atrophy (SMA) from the pivotal SUNFISH study. Data ... Seite 1
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease.